Determine AF Burden With PPG Trial - Detection and Quantification of Episodes of Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

July 28, 2022

Study Completion Date

July 30, 2022

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

PPG Smartwatch

Participants will then receive a PPG sensor in form of a smartwatch) model and will be instructed to wear them continuously for 48 hours. Simultaneously, a 48-hour Holter ECG will be performed. Start time on the PPG-sensor and the Holter ECG will be matched and continuous heart rhythm and -rate monitoring will be initiated. Patients will wear the devices over a 48-hour period of time.

Trial Locations (1)

4031

Universitiy Hospital Basel, Basel

All Listed Sponsors
collaborator

Preventicus GmbH

INDUSTRY

collaborator

Manufacture Modules Technologies SA

UNKNOWN

collaborator

GETEMED GmbH

UNKNOWN

collaborator

Eurostars

OTHER

lead

University Hospital, Basel, Switzerland

OTHER